TY - JOUR
T1 - Continental differences in the association between excess body weight and prognosis in triple-negative breast cancer
T2 - a meta-analysis
AU - Vaz-Goncalves, Larissa
AU - Protani, Melinda M.
AU - Saunus, Jodi M.
AU - Colditz, Graham A.
AU - Reeves, Marina M.
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2025/1
Y1 - 2025/1
N2 - Purpose: The association between obesity and triple-negative breast cancer (TNBC) prognosis has been equivocal, with considerable heterogeneity between and within studies. Recent meta-analyses report adverse associations with overall survival (OS) and disease-free survival (DFS) in TNBC. We update this evidence and examine study- and disease-specific sources of heterogeneity. Methods: A systematic search of four databases was conducted until February 22, 2023. Random-effects meta-analyses were used to pool hazard ratios (HR) for OS, DFS, and breast cancer-specific mortality (BCSM). Subgroup analyses examined sources of study heterogeneity. Results: In meta-analyses of included studies (n = 33), significant associations were observed between excess body weight and worse OS (n = 24; HR = 1.20; 95%CI 1.20–1.34), DFS (n = 26; HR = 1.15; 1.05–1.27), and BCSM (n = 9; HR = 1.13; 1.00–1.27). In subgroup meta-analyses, significant inter-study survival differences were observed for study location (OS, DFS), time period of diagnoses (DFS), menopausal status (OS), and body mass index cut points examined (OS). Asian and European studies reported significant associations with OS (HR = 1.31; 1.11–1.54 and HR = 1.38; 1.00–1.89, respectively) and DFS (HR = 1.28; 1.07–1.54 and HR = 1.44; 1.13–1.84, respectively); however, no association was observed between obesity and TNBC prognosis in North American studies (OS: HR = 1.03; 0.89–1.19; DFS: HR = 1.05; 0.95–1.15). Location subgroup differences remained robust after excluding poor-quality studies. Post hoc analysis in the subset of studies reporting predominantly (≥ 70%) White sample showed no statistically significant associations for OS (HR = 1.13; 95%CI 0.96, 1.34), DFS (HR = 1.03; 95%CI 0.86, 1.23), or BCSM (HR = 1.08; 95%CI 0.91, 1.27). Conclusion: This study further confirms that obesity is associated with poor prognosis in TNBC and identified subgroups at higher risk. Ethnic differences in the association between excess body weight and TNBC are reported. Further exploration of study and patient characteristics is needed to properly understand the populations most at risk.
AB - Purpose: The association between obesity and triple-negative breast cancer (TNBC) prognosis has been equivocal, with considerable heterogeneity between and within studies. Recent meta-analyses report adverse associations with overall survival (OS) and disease-free survival (DFS) in TNBC. We update this evidence and examine study- and disease-specific sources of heterogeneity. Methods: A systematic search of four databases was conducted until February 22, 2023. Random-effects meta-analyses were used to pool hazard ratios (HR) for OS, DFS, and breast cancer-specific mortality (BCSM). Subgroup analyses examined sources of study heterogeneity. Results: In meta-analyses of included studies (n = 33), significant associations were observed between excess body weight and worse OS (n = 24; HR = 1.20; 95%CI 1.20–1.34), DFS (n = 26; HR = 1.15; 1.05–1.27), and BCSM (n = 9; HR = 1.13; 1.00–1.27). In subgroup meta-analyses, significant inter-study survival differences were observed for study location (OS, DFS), time period of diagnoses (DFS), menopausal status (OS), and body mass index cut points examined (OS). Asian and European studies reported significant associations with OS (HR = 1.31; 1.11–1.54 and HR = 1.38; 1.00–1.89, respectively) and DFS (HR = 1.28; 1.07–1.54 and HR = 1.44; 1.13–1.84, respectively); however, no association was observed between obesity and TNBC prognosis in North American studies (OS: HR = 1.03; 0.89–1.19; DFS: HR = 1.05; 0.95–1.15). Location subgroup differences remained robust after excluding poor-quality studies. Post hoc analysis in the subset of studies reporting predominantly (≥ 70%) White sample showed no statistically significant associations for OS (HR = 1.13; 95%CI 0.96, 1.34), DFS (HR = 1.03; 95%CI 0.86, 1.23), or BCSM (HR = 1.08; 95%CI 0.91, 1.27). Conclusion: This study further confirms that obesity is associated with poor prognosis in TNBC and identified subgroups at higher risk. Ethnic differences in the association between excess body weight and TNBC are reported. Further exploration of study and patient characteristics is needed to properly understand the populations most at risk.
KW - Breast cancer subtype
KW - Ethnicity
KW - Obesity
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=85207867990&partnerID=8YFLogxK
U2 - 10.1007/s10549-024-07538-w
DO - 10.1007/s10549-024-07538-w
M3 - Review article
C2 - 39476311
AN - SCOPUS:85207867990
SN - 0167-6806
VL - 209
SP - 215
EP - 227
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 2
ER -